Profound Medical Corp. (PROF) Tops Q2 EPS by 79c

Profound Medical Corp. (NASDAQ: PROF) reported Q2 EPS of $0.52, $0.79 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.22 million versus the consensus estimate of $4.03 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• EU approves Gilead's Trodelvy for first-line metastatic TNBC
• Canaccord Resumes Calian Group Ltd (CGY:CN) (CLNFF) at Buy